COAGHemab Therapeutics Holdings Inc.

$26.94
$1.39
(5.44%)
Today
Closed $26.94
$0.00
(0.00%)
After Hours
Updated: 04:10 PM EDT
EarningsAug 14
Mkt Cap$1.19B
Vol190,950.00
49

Neutral Sentiment

How do you feel about COAG?

About

Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company. It engages in developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. The company was founded on February 12, 2026 and is headquartered in Cambridge, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
72

Frequently Asked Questions

What is Market Cap of Hemab Therapeutics Holdings Inc.?
What is the 52-week high for Hemab Therapeutics Holdings Inc.?
What is the 52-week low for Hemab Therapeutics Holdings Inc.?
What is Hemab Therapeutics Holdings Inc. stock price today?
What was Hemab Therapeutics Holdings Inc. stock price yesterday?
What is the Price-to-Book ratio of Hemab Therapeutics Holdings Inc.?
What is the 50-day moving average of Hemab Therapeutics Holdings Inc.?
How many employees does Hemab Therapeutics Holdings Inc. have?

Latest COAG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.